[[New antimicrobial agent series XLVII]: levofloxacin].
Saito
A
A
D000042:Absorption; D000328:Adult; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology; D001419:Bacteria / Q000187:drug effects; D001424:Bacterial Infections / Q000188:drug therapy; D004347:Drug Interactions; D005260:Female; D006801:Humans; D064704:Levofloxacin; D008297:Male; D051379:Mice; D008826:Microbial Sensitivity Tests; D015242:Ofloxacin / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D014018:Tissue Distribution
D000894:Anti-Inflammatory Agents, Non-Steroidal; D064704:Levofloxacin; D015242:Ofloxacin